Conatus Pharmaceuticals Total Assets 2012-2018 | CNAT

Conatus Pharmaceuticals total assets from 2012 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Conatus Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $49
2017 $82
2016 $82
2015 $40
2014 $38
2013 $57
2012 $8
2011 $0
Conatus Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q4 2018 $49
Q3 2018 $58
Q2 2018 $67
Q1 2018 $77
Q4 2017 $82
Q3 2017 $89
Q2 2017 $99
Q1 2017 $84
Q4 2016 $82
Q3 2016 $33
Q2 2016 $32
Q1 2016 $36
Q4 2015 $40
Q3 2015 $45
Q2 2015 $49
Q1 2015 $32
Q4 2014 $38
Q3 2014 $43
Q2 2014 $48
Q1 2014 $0
Q4 2013 $57
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $8
Q3 2012 $0
Q2 2012 $0
Q4 2011 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.023B $0.034B
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $130.875B 25.52
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Boston Scientific (BSX) United States $48.570B 23.60
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
Neogen (NEOG) United States $2.935B 47.73
NuVasive (NUVA) United States $2.870B 24.93
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00